Vitamin K deficiency bleeding and optimal prophylaxis methods in biliary atresia: A surveillance study in Japan

Ryuji Okubo1,2, Chiyoe Shirota3, Motoshi Wada1,2

  • 1The Japanese Biliary Atresia Society, The Office of the Japanese Biliary Atresia Society, Sendai, Japan.

Insights

The 3-month Vitamin K (VK) prophylaxis method effectively prevents VK deficiency bleeding (VKDB) in infants with biliary atresia (BA). Early diagnosis is crucial for managing VKDB and intracranial hemorrhage (ICH) risks.

Area of Science:

  • Pediatrics
  • Neonatology
  • Gastroenterology

Background:

  • Neonatal Vitamin K (VK) prophylaxis prevents VK deficiency bleeding (VKDB), a condition often causing intracranial hemorrhage (ICH).
  • This study examines VK prophylaxis methods and VKDB incidence in biliary atresia (BA) patients.

Purpose of the Study:

  • To investigate the relationship between different VK prophylaxis methods and VKDB in infants with biliary atresia.
  • To compare the efficacy of VK prophylaxis regimens in preventing VKDB and assess associated outcomes.

Main Methods:

  • A comparative study using propensity score matching analyzed 289 biliary atresia cases from the Japanese Biliary Atresia Registry (2015-2019).
  • Patients were categorized based on VK prophylaxis methods (three-times vs. 3-month).
  • Outcomes including VKDB, ICH, jaundice disappearance, cholangitis, and native liver survival rates (NLSRs) were evaluated.

Main Results:

  • No VKDB cases occurred with the 3-month VK prophylaxis method.
  • The three-times method was associated with higher VKDB rates compared to the 3-month method.
  • No significant differences in jaundice disappearance, cholangitis, or NLSRs were observed between groups; however, the ICH group showed developmental delays.

Conclusions:

  • The 3-month VK prophylaxis method is effective in preventing VKDB in biliary atresia patients.
  • Early diagnosis and intervention are critical for managing VKDB and its complications, including ICH.
Abstract